Verition Fund Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.61M | Sell |
|
|||||
|
2025
Q2 | $1.25M | Sell |
|
|||||
|
2025
Q1 | $2.86M | Buy |
|
|||||
|
2024
Q4 | $1.86M | Buy |
|
|||||
|
2024
Q3 | $586K | Buy |
|
|||||
|
2024
Q2 | $593K | Sell |
|
|||||
|
2024
Q1 | $1.45M | Buy |
|
|||||
|
2023
Q4 | $205K | Sell |
|
|||||
|
2023
Q3 | $341K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.2M | Buy |
|
|||||
|
2022
Q4 | $208K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $252K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $239K | Buy |
|